Philips highlights enhanced PET/CT, green BrightView SPECT

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Royal Philips Electronics this week at SNM 2007 in Washington, D.C., announced enhancements to Philips GEMINI TF PET/CT, a time-of-flight PET/CT, and the nuclear medicine debut of a “green” BrightView SPECT, among other technologies.

 “The breadth of our nuclear medicine products and solutions in PET, SPECT, molecular imaging (MI), preclinical imaging and radiation oncology promote clinical confidence for the physician and peace of mind for the patient,” said Jay Mazelsky, senior vice president, nuclear medicine, for Philips Medical Systems. “Philips recognizes the importance of accurately viewing the physiological process at a molecular level and works to develop technologies that help our customers detect pathology earlier, faster and more accurately.”

Philips emphasized that its installed for the GEMINI TF PET/CT is growing, with more than 30 installed systems worldwide. The GEMINI TF with time-of-flight imaging has demonstrated improved image quality, reduced dose, faster scan times, and consistent image quality across all patient sizes.

Dr. Jim O’Donnell, section chief of Nuclear Imaging at University Hospitals Case Medical Center said of the system, “We’ve really gone another giant step forward in image resolution with time-of-flight. And the differential improvement in moving from conventional PET to time-of-flight is most prominent in larger patients because it overcomes the inherent physiological problems of size. The system really cleans up the scans in these larger patients.”

Also on display was the company’s compact BrightView SPECT. The system’s BodyGuard feature automatically contours to the patient, using a customizable scan distance preset by the operator. Also, Philips’ CloseUp technologies enable higher resolution through smart software, new electronics and minimal distance between detector and patient.

Philips also boasted that the BrightView is also its “green flagship” product, thus BrightView with a sustainable life cycle in mind, using less than 50 percent of the hazardous substances found in its predecessor. BrightView is also designed to offer significant advances on packaging, recycling and disposal.

The company also showcased its MOSAIC HP, a part Philips’ comprehensive preclinical imaging product portfolio. The system has extra-long imaging bore and long axial field of view, useful for a variety of research subjects as well as the capability to perform bio-distribution studies on a whole subject (mice) in a single bed position. Equipped with a high performance LYSO detector and optional subject handling system compatible with the NanoSPECT/CT system, MOSAIC HP addresses the key requirements of research scientists and is setting new standards in preclinical molecular imaging.

Other highlights at the show included:

  • PET/CT Pulmonary Toolkit for Respiratory Correlated Imaging – Respiratory correlated imaging applied to PET improves the accuracy of PET attenuation correction and Standard Uptake Value (SUV) calculations, assists in small lesion detection and facilitates more precise localization;

  • PET/CT Viewer for Philips iSite PACS and version 1.5, providing users with an integrated, powerful, yet simple image review and analysis environment for routine clinical evaluation of PET/CT examinations. Philips has extended the availability of the PET/CT Viewer beyond the Philips Extended Brilliance Workspace to the Philips iSite PACS, along with introducing the latest release of version 1.5;
  • NetForum PET/CT Community – Previously available to Philips CT and MR customers only, the NetForum PET/CT community is connecting Philips PET/CT customers from around the globe in a moderated virtual users meeting to share clinical experiences, learn from each other and optimize results;
  • NanoSPECT/CT – Available through a distribution agreement with Bioscan Inc. announced earlier this year, NanoSPECT/CT will help accelerate preclinical research, the discovery of new targeted biomarkers and the development and validation of new molecular diagnostic and therapeutic applications; and
  • Philips announced the commercial release of the JETStream Workspace 3.0, an integrated, personalized workflow solution for nuclear medicine that includes new process and image display enhancements, new image analysis tools and upgraded clinical applications for cardiac, bone, renal, salivary, lung and brain studies.